ORBIMED ADVISORS LLC purchased 2.82M shares of PRELUDE THERAPEUTICS INC on the open market
Open‑market purchase worth $12.50M. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/23/2026ACC: 0000947871-26-000461
Director10% Owner
Since Sep 2020
+2.82M
Net shares
Net buyer
$12.50M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
2.82M acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.69M
Price / share
$4.44
Trade value
$7.50M
% of position
16.7%
4/21/2026
10.12M→11.81M
Common Stock
Indirect
Shares
+1.13M
Price / share
$4.44
Trade value
$5M
% of position
New position
4/21/2026
0.00→1.13M
Total
Net shares
+2.82M
Net value
$12.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/21/2026 | P · Purchase | +1.69M | $4.44 | $7.50M | 16.7% | 10.12M | 11.81M |
| Common Stock Indirect | 4/21/2026 | P · Purchase | +1.13M | $4.44 | $5M | New position | 0.00 | 1.13M |
| Total | +2.82M | $12.50M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned526.30K
Total
526.30K indirect526.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 526.30K | Indirect |
| Total | 526.30K | 526.30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported